BridgeMD
A Prospective Real-World Evidence Study evaluating the effects of Voltaren use on Mobility and QoL of subjects with knee osteoarthritis (OA) pain.
EU CTIS ID: 2024-510839-22-00
What this study is testing
To evaluate the effects of Voltaren Gel on physical activity, measured through connected activity tracker.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- • A Subject between the age of 40 and 85 years.
- • A subject with diagnosed knee mild/non-serious osteoarthritis, proven via radiological evidence collected within the last 3 years.
- • A subject with self-reported knee pain, with a score of ≥ 40 mm ≤ 70mm on the pain intensity visual analogue scale at the Screening Visit.
- • A subject willing to use Voltaren Gel for up to 3 weeks.
You likely can't join if
- • A subject with confirmed rheumatologic disease
- • A subject who has experienced trauma to the knee within the last 2 months that resulted in pain and/or swelling.
- • A subject that has been administered local steroids or other NSAIDs injections to the knee within the last 3 months.
- • A subject with recent history of major knee injury or surgery.
- • A subject with knee skin area pathological condition which prevents application of product to the skins. Conditions such as: open skin wounds, infections, inflammations, or exfoliative dermatitis conditions.
- • A subject who is pregnant, lactating or plan to be pregnant or lactating during the study.
The study team makes the final eligibility decision.
Where it's taking place
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.